Jinyu Bio-technology Co., Ltd. (SHA:600201)
China
· Delayed Price · Currency is CNY 14.89
-0.06 (-0.40%)
Mar 9, 2026, 3:00 PM CST
Jinyu Bio-technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 16,271 | 7,663 | 11,711 | 9,846 | 18,287 | 23,527 | Upgrade
|
| Market Cap Growth | 120.36% | -34.56% | 18.94% | -46.16% | -22.27% | 11.59% | Upgrade
|
| Enterprise Value | 15,082 | 6,475 | 10,150 | 8,877 | 16,727 | 21,846 | Upgrade
|
| Last Close Price | 14.89 | 6.83 | 10.60 | 8.81 | 15.80 | 20.04 | Upgrade
|
| PE Ratio | 154.98 | 70.31 | 41.29 | 46.74 | 47.84 | 57.92 | Upgrade
|
| Forward PE | 87.59 | 21.05 | 31.48 | 23.75 | 22.33 | 38.03 | Upgrade
|
| PS Ratio | 12.26 | 6.10 | 7.33 | 6.44 | 10.30 | 14.87 | Upgrade
|
| PB Ratio | 2.88 | 1.42 | 2.07 | 1.84 | 3.29 | 4.47 | Upgrade
|
| P/TBV Ratio | 3.33 | 1.62 | 2.34 | 2.10 | 3.82 | 5.22 | Upgrade
|
| P/FCF Ratio | 87.07 | 38.34 | 82.67 | 63.71 | 114.01 | 49.92 | Upgrade
|
| P/OCF Ratio | 60.28 | 26.47 | 28.23 | 28.57 | 34.30 | 33.63 | Upgrade
|
| PEG Ratio | - | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | Upgrade
|
| EV/Sales Ratio | 11.37 | 5.16 | 6.35 | 5.81 | 9.42 | 13.81 | Upgrade
|
| EV/EBITDA Ratio | 88.78 | 26.26 | 23.22 | 19.69 | 28.59 | 37.62 | Upgrade
|
| EV/EBIT Ratio | - | 174.08 | 40.81 | 35.23 | 42.43 | 53.68 | Upgrade
|
| EV/FCF Ratio | 80.71 | 32.39 | 71.64 | 57.44 | 104.28 | 46.35 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | 0.07 | 0.01 | 0.02 | 0.00 | - | Upgrade
|
| Debt / FCF Ratio | 0.09 | 0.09 | 0.03 | 0.07 | 0.01 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.21 | -0.31 | -0.27 | -0.27 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -8.16 | -4.70 | -3.99 | -3.20 | -2.59 | -3.71 | Upgrade
|
| Net Debt / FCF Ratio | -7.34 | -5.80 | -12.32 | -9.33 | -9.46 | -4.57 | Upgrade
|
| Asset Turnover | 0.20 | 0.18 | 0.24 | 0.24 | 0.28 | 0.27 | Upgrade
|
| Inventory Turnover | 2.44 | 1.94 | 2.04 | 2.14 | 2.06 | 2.09 | Upgrade
|
| Quick Ratio | 2.93 | 2.58 | 3.17 | 3.53 | 3.34 | 4.15 | Upgrade
|
| Current Ratio | 3.44 | 3.02 | 3.59 | 4.07 | 4.01 | 4.69 | Upgrade
|
| Return on Equity (ROE) | 1.66% | 1.88% | 5.04% | 3.67% | 7.19% | 8.34% | Upgrade
|
| Return on Assets (ROA) | -0.52% | 0.34% | 2.34% | 2.42% | 3.82% | 4.29% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.11% | 0.76% | 5.58% | 5.17% | 10.38% | 11.58% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.90% | 0.60% | 4.10% | 4.40% | 6.70% | 7.30% | Upgrade
|
| Earnings Yield | 0.62% | 1.42% | 2.42% | 2.14% | 2.09% | 1.73% | Upgrade
|
| FCF Yield | 1.15% | 2.61% | 1.21% | 1.57% | 0.88% | 2.00% | Upgrade
|
| Dividend Yield | 0.20% | 0.44% | 0.76% | 0.68% | 0.70% | 0.60% | Upgrade
|
| Payout Ratio | 34.58% | 82.00% | 23.55% | 59.04% | 35.11% | 16.52% | Upgrade
|
| Buyback Yield / Dilution | 5.26% | 0.10% | 1.61% | 1.39% | 0.35% | -2.09% | Upgrade
|
| Total Shareholder Return | 5.46% | 0.53% | 2.37% | 2.07% | 1.05% | -1.49% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.